We are live on ! Find out more
BL

Bleichroeder LP Portfolio holdings

AUM $559M Turnover 17.24%
1-Year Est. Return 83.7%
This Fund
S&P 500
This Quarter Est. Return
+27%
1 Year Est. Return
+83.7%
3 Year Est. Return
+202.15%
5 Year Est. Return
+208.71%
10 Year Est. Return
–
AUM
$568M
AUM Growth
+$55.3M
Cap. Flow
+$7.09M
Cap. Flow %
1.25%
Top 10 Hldgs %
82.48%
Holding
77
New
5
Increased
9
Reduced
4
Closed
4
Avg Time Held
2.9 years
Top 10 Avg Time Held
2.1 years
Top 20 Avg Time Held
2.5 years

Top Buys

Rank Stock Value
1
KZIA icon
Kazia Therapeutics
KZIA
+$3.41M
2
DTIL icon
Precision BioSciences
DTIL
+$3.33M
3
PXLW icon
Pixelworks
PXLW
+$1.54M
4
GPGI icon
GPGI Inc
GPGI
+$1.1M
5
EYPT icon
EyePoint Inc
EYPT
+$850K

Top Sells

Rank Stock Value
1
LIN icon
Linde
LIN
+$3M
2
CMPOW icon
CompoSecure Inc Warrant
CMPOW
+$1.28M
3
FEAM icon
5E Advanced Materials
FEAM
+$997K
4
EVOK icon
Evoke Pharma
EVOK
+$728K
5
GPCR icon
Structure Therapeutics
GPCR
+$408K

Sector Composition

Rank Sector Weight
1 Miscellaneous 37.76%
2 Industrials 28.25%
3 Healthcare 13.73%
4 Technology 6.13%
5 Materials 5.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
QQQ icon
26
Invesco QQQ Trust
QQQ
$487B
$2.85M 0.5%
4,640
– –
2025 Q2
2 quarters
KZIA icon
27
Kazia Therapeutics
KZIA
$115M
$2.76M 0.49%
+400,000
New +$3.41M
2025 Q4
0 quarters
CUE icon
28
Cue Biopharma
CUE
$136M
$2.08M 0.37%
227,305
– –
2019 Q4
24 quarters
PROF icon
29
Profound Medical
PROF
$231M
$2M 0.35%
254,753
+71,420
+39% +$459K
2023 Q4
8 quarters
VENU icon
30
Venu Holding Corp
VENU
$65.6M
$1.68M 0.3%
200,000
– –
2025 Q3
1 quarter
IRD icon
31
Opus Genetics
IRD
$337M
$1.48M 0.26%
736,842
– –
2025 Q1
3 quarters
PXLW icon
32
Pixelworks
PXLW
$33M
$1.28M 0.23%
+201,015
New +$1.54M
2025 Q4
0 quarters
LLYVK icon
33
Liberty Live Group Series C
LLYVK
$9.17B
$1.17M 0.21%
13,802
– –
2023 Q3
9 quarters
CRIS icon
34
Curis
CRIS
$1.23M
$1.12M 0.2%
56,783
– –
2020 Q4
20 quarters
RTX icon
35
RTX Corp
RTX
$252B
$1.1M 0.19%
6,000
– –
2020 Q2
22 quarters
MODD icon
36
Modular Medical
MODD
$20.5M
$1.04M 0.18%
95,319
+28,166
+42% +$414K
2024 Q1
7 quarters
TLPH icon
37
Talphera
TLPH
$55.5M
$1M 0.18%
881,166
– –
2025 Q1
3 quarters
POCI icon
38
Precision Optics
POCI
$47.7M
$922K 0.16%
220,230
– –
2024 Q3
5 quarters
GPCR icon
39
Structure Therapeutics
GPCR
$1.58B
$696K 0.12%
10,000
-10,000
-50% -$408K
2023 Q4
8 quarters
ICCC icon
40
ImmuCell
ICCC
$95.9M
$625K 0.11%
101,594
– –
2021 Q2
18 quarters
LWLG icon
41
Lightwave Logic
LWLG
$648M
$538K 0.09%
+166,000
New +$737K
2025 Q4
0 quarters
RNXT icon
42
RenovoRx
RNXT
$53.7M
$504K 0.09%
600,000
+61,379
+11% +$61.5K
2025 Q1
3 quarters
LLYVA icon
43
Liberty Live Group Series A
LLYVA
$8.87B
$502K 0.09%
6,047
– –
2023 Q3
9 quarters
LHX icon
44
L3Harris
LHX
$44.8B
$470K 0.08%
1,600
– –
2019 Q4
24 quarters
PHYS icon
45
Sprott Physical Gold
PHYS
$14.9B
$414K 0.07%
12,540
– –
2019 Q4
24 quarters
IPWR icon
46
Ideal Power
IPWR
$52.8M
$411K 0.07%
133,000
– –
2024 Q1
7 quarters
AZ icon
47
A2Z Smart Technologies
AZ
$254M
$404K 0.07%
62,000
– –
2025 Q3
1 quarter
OPFI.WS icon
48
DELISTED
OppFi Inc Warrants
OPFI.WS
$383K 0.07%
250,000
– –
2021 Q3
17 quarters
MSAI icon
49
MultiSensor AI
MSAI
$9.48M
$352K 0.06%
30,562
+13,062
+75% +$381K
2024 Q2
6 quarters
CARR icon
50
Carrier Global
CARR
$45.3B
$317K 0.06%
6,000
– –
2020 Q2
22 quarters
1
2
3 4

Similar funds

NFW
Noble Family Wealth Clearwater, Florida $559M AUM 24.35% 1-Year Est. Return
SCM
Soros Capital Management New York $559M AUM 171.77% 1-Year Est. Return
PHC
Palidye Holdings (Caymans) Grand Cayman, Cayman Islands $559M AUM 1.08% 1-Year Est. Return
EPM
Equitec Proprietary Markets Chicago, Illinois $559M AUM 230.29% 1-Year Est. Return
BCM
Brasada Capital Management Houston, Texas $558M AUM 21.68% 1-Year Est. Return
FAM
Frontier Asset Management Sheridan, Wyoming $558M AUM 22.41% 1-Year Est. Return
WDG
Wealth Dimensions Group Cincinnati, Ohio $558M AUM 20.63% 1-Year Est. Return
OC
Opal Capital Boca Raton, Florida $560M AUM

Bleichroeder LP's Q4 2025 Portfolio in Review

As of Q4 2025, Bleichroeder LP held 77 positions worth $568M, up 11% from $513M the previous quarter. Its ten largest holdings account for 82% of the portfolio.

Bleichroeder LP's Q4 2025 filing shows 5 new, 9 increased, 4 reduced and 4 closed positions. Its largest new stake was Kazia Therapeutics: 400,000 shares worth $2.76M. The largest sale was Linde, an estimated $3M.

By sector, the portfolio is most concentrated in Miscellaneous at 38% of assets, down from 38% a quarter earlier, followed by Industrials and Healthcare.

  • Bleichroeder LP's largest Q4 2025 buy was Kazia Therapeutics: 400,000 shares worth $2.76M.
  • Bleichroeder LP added most to Precision BioSciences in Q4 2025, an estimated $3.33M increase.
  • Bleichroeder LP's biggest Q4 2025 reduction was Linde, cutting an estimated $3M.
  • Bleichroeder LP fully exited CompoSecure Inc Warrant in Q4 2025, selling an estimated $1.28M.
  • Bleichroeder LP's ten largest holdings make up 82% of its $568M portfolio in Q4 2025.
  • Bleichroeder LP opened 5 new positions and closed 4 in Q4 2025.
  • Bleichroeder LP's portfolio value rose 11% quarter-over-quarter to $568M.

Based on Bleichroeder LP's 13F filing for Q4 2025, filed 13 Feb 2026.